eMyosound

eMyosound is a French med-tech company founded in 2022, focused on developing innovative, non-invasive medical devices for diagnosing heart failure and other cardiac diseases. The company utilizes advanced ultrasound technology, specifically ultrasound elastography and shear wave technology, to assess the biomechanical properties of cardiac tissue. This approach provides precise insights into heart function and stiffness. The core product is a medical device that employs ultrasound elastography to evaluate cardiac health. It quantifies cardiac rigidity through artificial intelligence-based analysis, enabling cardiologists to non-invasively diagnose conditions such as heart failure and hypertrophic cardiomyopathy. This technology offers a fast, scalable, and cost-effective method for cardiac evaluation, enhancing clinical decision-making and patient management. Headquartered at PariSanté Campus in Paris, eMyosound emphasizes quality and regulatory compliance while collaborating with leading academic and medical institutions. The company aims to be a global leader in non-invasive heart failure diagnosis, providing healthcare professionals with advanced tools to improve patient outcomes in cardiac care.

• Employees 13
• Founded 2022